Eurofins Scientific SE

ENXTPA:ERF Stock Report

Market Cap: €10.7b

Eurofins Scientific Past Earnings Performance

Past criteria checks 1/6

Eurofins Scientific has been growing earnings at an average annual rate of 18.5%, while the Life Sciences industry saw earnings growing at 19.6% annually. Revenues have been growing at an average rate of 11.4% per year. Eurofins Scientific's return on equity is 6%, and it has net margins of 3.9%.

Key information

18.5%

Earnings growth rate

17.3%

EPS growth rate

Life Sciences Industry Growth26.8%
Revenue growth rate11.4%
Return on equity6.0%
Net Margin3.9%
Next Earnings Update24 Jul 2024

Recent past performance updates

Recent updates

Does Eurofins Scientific (EPA:ERF) Have A Healthy Balance Sheet?

Nov 10
Does Eurofins Scientific (EPA:ERF) Have A Healthy Balance Sheet?

Eurofins Scientific SE's (EPA:ERF) Intrinsic Value Is Potentially 64% Above Its Share Price

Oct 23
Eurofins Scientific SE's (EPA:ERF) Intrinsic Value Is Potentially 64% Above Its Share Price

We Think Eurofins Scientific (EPA:ERF) Is Taking Some Risk With Its Debt

Aug 07
We Think Eurofins Scientific (EPA:ERF) Is Taking Some Risk With Its Debt

Are Investors Undervaluing Eurofins Scientific SE (EPA:ERF) By 25%?

Jul 20
Are Investors Undervaluing Eurofins Scientific SE (EPA:ERF) By 25%?

We Think Eurofins Scientific (EPA:ERF) Can Stay On Top Of Its Debt

May 03
We Think Eurofins Scientific (EPA:ERF) Can Stay On Top Of Its Debt

Eurofins Scientific SE (EPA:ERF) Shares Could Be 21% Above Their Intrinsic Value Estimate

Apr 11
Eurofins Scientific SE (EPA:ERF) Shares Could Be 21% Above Their Intrinsic Value Estimate

Estimating The Intrinsic Value Of Eurofins Scientific SE (EPA:ERF)

Jan 05
Estimating The Intrinsic Value Of Eurofins Scientific SE (EPA:ERF)

Here's Why Eurofins Scientific (EPA:ERF) Can Manage Its Debt Responsibly

Dec 14
Here's Why Eurofins Scientific (EPA:ERF) Can Manage Its Debt Responsibly

An Intrinsic Calculation For Eurofins Scientific SE (EPA:ERF) Suggests It's 33% Undervalued

Oct 03
An Intrinsic Calculation For Eurofins Scientific SE (EPA:ERF) Suggests It's 33% Undervalued

Does Eurofins Scientific (EPA:ERF) Have A Healthy Balance Sheet?

Sep 06
Does Eurofins Scientific (EPA:ERF) Have A Healthy Balance Sheet?

Eurofins Scientific (EPA:ERF) Is Increasing Its Dividend To €1.00

Jun 25
Eurofins Scientific (EPA:ERF) Is Increasing Its Dividend To €1.00

Are Investors Undervaluing Eurofins Scientific SE (EPA:ERF) By 39%?

Jun 16
Are Investors Undervaluing Eurofins Scientific SE (EPA:ERF) By 39%?

Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet

Jun 01
Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet

Should You Be Adding Eurofins Scientific (EPA:ERF) To Your Watchlist Today?

Apr 12
Should You Be Adding Eurofins Scientific (EPA:ERF) To Your Watchlist Today?

These 4 Measures Indicate That Eurofins Scientific (EPA:ERF) Is Using Debt Safely

Feb 25
These 4 Measures Indicate That Eurofins Scientific (EPA:ERF) Is Using Debt Safely

Is Eurofins Scientific SE (EPA:ERF) Worth €114 Based On Its Intrinsic Value?

Nov 28
Is Eurofins Scientific SE (EPA:ERF) Worth €114 Based On Its Intrinsic Value?

Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet

Nov 14
Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet

Here's Why I Think Eurofins Scientific (EPA:ERF) Might Deserve Your Attention Today

Sep 30
Here's Why I Think Eurofins Scientific (EPA:ERF) Might Deserve Your Attention Today

Are Eurofins Scientific SE (EPA:ERF) Investors Paying Above The Intrinsic Value?

Aug 29
Are Eurofins Scientific SE (EPA:ERF) Investors Paying Above The Intrinsic Value?

We Think Eurofins Scientific (EPA:ERF) Can Manage Its Debt With Ease

Aug 15
We Think Eurofins Scientific (EPA:ERF) Can Manage Its Debt With Ease

Do Eurofins Scientific's (EPA:ERF) Earnings Warrant Your Attention?

Jun 24
Do Eurofins Scientific's (EPA:ERF) Earnings Warrant Your Attention?

Estimating The Fair Value Of Eurofins Scientific SE (EPA:ERF)

May 25
Estimating The Fair Value Of Eurofins Scientific SE (EPA:ERF)

Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet

Mar 31
Eurofins Scientific (EPA:ERF) Has A Rock Solid Balance Sheet

Does Eurofins Scientific (EPA:ERF) Deserve A Spot On Your Watchlist?

Mar 17
Does Eurofins Scientific (EPA:ERF) Deserve A Spot On Your Watchlist?

Eurofins Scientific SE (EPA:ERF) Has Got What It Takes To Be An Attractive Dividend Stock

Mar 03
Eurofins Scientific SE (EPA:ERF) Has Got What It Takes To Be An Attractive Dividend Stock

Eurofins Scientific SE Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Mar 03
Eurofins Scientific SE Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Are Institutions Heavily Invested In Eurofins Scientific SE's (EPA:ERF) Shares?

Feb 15
Are Institutions Heavily Invested In Eurofins Scientific SE's (EPA:ERF) Shares?

Is Eurofins Scientific's (EPA:ERF) 117% Share Price Increase Well Justified?

Dec 28
Is Eurofins Scientific's (EPA:ERF) 117% Share Price Increase Well Justified?

How Does Eurofins Scientific's (EPA:ERF) CEO Pay Compare With Company Performance?

Dec 14
How Does Eurofins Scientific's (EPA:ERF) CEO Pay Compare With Company Performance?

Eurofins Scientific (EPA:ERF) Is Growing Earnings But Are They A Good Guide?

Nov 30
Eurofins Scientific (EPA:ERF) Is Growing Earnings But Are They A Good Guide?

Revenue & Expenses Breakdown
Beta

How Eurofins Scientific makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

ENXTPA:ERF Revenue, expenses and earnings (EUR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 236,5152571360
30 Sep 236,5123351320
30 Jun 236,5104141410
31 Mar 236,6114971410
31 Dec 226,7125811280
30 Sep 226,7856121230
30 Jun 226,8576431170
31 Mar 226,7876961160
31 Dec 216,7187491150
30 Sep 216,5537861170
30 Jun 216,3888241180
31 Mar 215,9136651190
31 Dec 205,4395051190
30 Sep 205,0793471200
30 Jun 204,7191901200
31 Mar 204,6411681190
31 Dec 194,5631461170
30 Sep 194,3841441110
30 Jun 194,2051431060
31 Mar 193,993159980
31 Dec 183,781175900
30 Sep 183,549182820
30 Jun 183,318190750
31 Mar 183,145185620
31 Dec 172,971179480
30 Sep 172,848166420
30 Jun 172,725152350
31 Mar 172,631145370
31 Dec 162,537138380
30 Sep 162,427104350
30 Jun 162,31769320
31 Mar 162,13363310
31 Dec 151,95056300
30 Sep 151,77971270
30 Jun 151,60986240
31 Mar 151,50982200
31 Dec 141,41078150
30 Sep 141,35566170
30 Jun 141,29953190
31 Mar 141,26253150
31 Dec 131,22653120
30 Sep 131,1806180
30 Jun 131,1346950
31 Mar 131,0896860

Quality Earnings: ERF has a large one-off loss of €189.2M impacting its last 12 months of financial results to 31st December, 2023.

Growing Profit Margin: ERF's current net profit margins (3.9%) are lower than last year (8.7%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: ERF's earnings have grown by 18.5% per year over the past 5 years.

Accelerating Growth: ERF's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: ERF had negative earnings growth (-55.8%) over the past year, making it difficult to compare to the Life Sciences industry average (0.4%).


Return on Equity

High ROE: ERF's Return on Equity (6%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.